Invention Grant
- Patent Title: Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
-
Application No.: US14298673Application Date: 2014-06-06
-
Publication No.: US10966968B2Publication Date: 2021-04-06
- Inventor: Rene Braeckman , William Stirtan , Paresh Soni
- Applicant: Amarin Pharmaceuticals Ireland Limited
- Applicant Address: IE Dublin
- Assignee: Amarin Pharmaceuticals Ireland Limited
- Current Assignee: Amarin Pharmaceuticals Ireland Limited
- Current Assignee Address: IE Dublin
- Agency: Perkins Coie LLP
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/557 ; A61K31/202
Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing triglycerides in a subject on rosiglitazone therapy, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
Public/Granted literature
- US20140364459A1 CO-ADMINISTRATION OF ROSIGLITAZONE AND EICOSAPENTAENOIC ACID OR A DERIVATIVE THEREOF Public/Granted day:2014-12-11
Information query
IPC分类:
